/tech

AI drug discovery deals are typically smaller in Europe than North America, Tech Funding News reports

Tech Funding News says a typical AI drug discovery deal is around $4.5 million in Europe versus $47 million in North America.

/tech

AI drug discovery deals are typically smaller in Europe than North America, Tech Funding News reports · Digg

AI drug discovery deals are typically smaller in Europe than North America, Tech Funding News reports

Tech Funding News says a typical AI drug discovery deal is around $4.5 million in Europe versus $47 million in North America.

Tech Funding News reports a funding gap in AI drug discovery, putting a typical European deal at around $4.5 million compared with $47 million in North America. The publisher also describes 12 European AI biotech startups nominated by venture capitalists to watch in 2026, including companies working on clinical trial automation.

Today's Rank

—

Not ranked yet

Combined views

1 post, first seen 4d ago

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

AI drug discovery deals are typically smaller in Europe than North America, Tech Funding News reports

Tech Funding News says a typical AI drug discovery deal is around $4.5 million in Europe versus $47 million in North America.

Posts from X

1 post

TF
Tech Funding News@TFNBreakingNews 4 days ago
💰 Europe’s biotech funding gap is getting harder to ignore. A typical AI drug discovery deal in Europe is around $4.5M, versus $47M in North America. #biotech #ai #drugdiscovery #startups #venturecapital #eutech #deeptech #technology
techfundingnews.com
12 European biotech startups to watch, according to top VCs — TFN
European VCs nominate 12 AI biotech startups to watch in 2026 across next-gen ADCs, clinical trial automation, multi-omics, and biological foundation models.
- likes: 0
- replies: 0
- bookmarks: 0
- reposts: 0

Posts from X

1 post

TF
Tech Funding News@TFNBreakingNews 4 days ago
💰 Europe’s biotech funding gap is getting harder to ignore. A typical AI drug discovery deal in Europe is around $4.5M, versus $47M in North America. #biotech #ai #drugdiscovery #startups #venturecapital #eutech #deeptech #technology
techfundingnews.com
12 European biotech startups to watch, according to top VCs — TFN
European VCs nominate 12 AI biotech startups to watch in 2026 across next-gen ADCs, clinical trial automation, multi-omics, and biological foundation models.
- likes: 0
- replies: 0
- bookmarks: 0
- reposts: 0

Today's Rank

—

Not ranked yet

Combined views

1 post, first seen 4d ago

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Source Posts

@TFNBreakingNews💰 Europe’s biotech funding gap is getting harder to ignore. A typical AI drug discovery deal in Europe is around $4.5M, versus $47M in North America. https://techfundingnews.com/european-biotech-startups-to-watch-top-vcs-2026/ #biotech #ai #drugdiscovery #startups #venturecapital #eutech #deeptech #technology

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Source Posts

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Today's Rank

—

Not ranked yet

Today's Rank

—

Not ranked yet

Posts from X

1 post

TF
Tech Funding News@TFNBreakingNews 4 days ago
💰 Europe’s biotech funding gap is getting harder to ignore. A typical AI drug discovery deal in Europe is around $4.5M, versus $47M in North America. #biotech #ai #drugdiscovery #startups #venturecapital #eutech #deeptech #technology
techfundingnews.com
12 European biotech startups to watch, according to top VCs — TFN
European VCs nominate 12 AI biotech startups to watch in 2026 across next-gen ADCs, clinical trial automation, multi-omics, and biological foundation models.
- likes: 0
- replies: 0
- bookmarks: 0
- reposts: 0